Emmanuel Papadakis

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Emmanuel Papadakis works at DEUTSCHE BANK and is focused on the Healthcare sector with 141 price targets and ratings documented since 2017 spanning on 12 stocks. Analyst's average stock valuation to be materialised ratio is 63.08% with an average time for price targets to be met of 245.56 days.

Most recent stock forecast was given on ALVO, at 07-Mar-2023.

Emmanuel Papadakis best performing recommendations are on MRNA (MODERNA, INC).
The best stock recommendation documented was for MRNA (MODERNA, INC) at 3/7/2022. The price target of $155 was fulfilled within 9 days with a profit of $28.54 (22.57%) receiving and performance score of 25.08.

Average potential price target upside

of $39.25 (12.35%) on MRNA (MODERNA, INC).
of $9.52 (11.93%) on NVO.
of $4.35 (7.09%) on NVS (NOVARTIS AG).

Currently, out of the existing stock ratings of Emmanuel Papadakis - 5221 which are a Buy (50.31%), 2549 which are a Hold (24.56%), 2607 which are a Sell (25.12%)